| D14 | Clinical and psychosocial determinants of adherence: results from the MaxART clustered randomized stepped wedge trial of early access to ART | E-poster | Adherence to HIV treatment |
| D14 | High viral suppression among clients with high viral load after implementing multifaceted interventions in a clinic setting in Eswatini | E-poster | Adherence to HIV treatment |
| D14 | Using private pharmacies for decentralized distribution of antiretroviral therapy: early lessons from seven sub-Saharan African countries | E-poster | Adherence to HIV treatment |
| C48 | Demographic factors associated with continuation of oral anti-retroviral HIV pre-exposure prophylaxis at one and three months in Nairobi, Kenya | E-poster | Adherence to HIV prevention strategies |
| C48 | Persistence on oral pre-exposure prophylaxis (PrEP) among female sex workers in Durban, South Africa from 2016-2020 | E-poster | Adherence to HIV prevention strategies |
| C48 | Effectiveness of participant-driven follow-up strategy on retention among young female sex workers in Kampala, Uganda | E-poster | Adherence to HIV prevention strategies |
| C48 | Interim feasibility results of a pre-exposure prophylaxis (PrEP) delivery demonstration project among male sex workers in Malindi, Kenya | E-poster | Adherence to HIV prevention strategies |
| B40 | Self-reported antiretroviral adherence: association with maternal viral load suppression in HIV-1-infected postpartum women in Promoting Maternal and Infant Survival Everywhere (PROMISE): randomized, open label trial in sub-Saharan Africa and India | E-poster | Adherence measurement |
| B40 | Estimating minimum adherence required for plasma HIV-1 RNA viral load suppression among people who use unregulated drugs in Vancouver, Canada | E-poster | Adherence measurement |
| B40 | Utilization of antiretroviral refill histories as a predictor of future HIV viremia | E-poster | Adherence measurement |